Article
Toxic oil syndrome: genetic restriction and immunomodulatory effects due to adulterated oils in a model of HLA transgenic mice.
Toxicology letters - 15 Nov 2005
Gallardo Soledad, Cárdaba Blanca, Posada Manuel, del Pozo Victoria, Messeguer Angel, David Chella S, Lahoz Carlos
Abstract excerpt
Toxic oil syndrome (TOS) was described in Spain in 1981, due to the ingestion of contaminated rapeseed oil denatured with 2% aniline. More than 20,000 persons were affected, causing over 2500 deaths. Immunological findings were: eosinophilia, mRNA for Th2 cytokines (IL-4 and IL-5) in lungs, elevated total IgE and sIL-2R and increase of DR2 HLA class II phenotypic frequency in patients died by TOS. Our objective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
